Neurodan gets EU approval to launch implant cure for foot drop  

Neurodan, a neural implants company based in Aalborg, Jutland, has gained EU approval for sales of its ActiGait product for foot drop
Neurodan, a neural implants company based in Aalborg, Jutland, which was acquired last year by Germany's Otto Bock HealthCare, has obtained EU approval for its implanted foot drop correction system  ActiGait. The first implant operation is scheduled to be carried out at a Danish hospital in November, followed by several more operations at hospitals in Germany in H1 2007.
A key benefit of ActiGait implant is that by providing local neuromuscular stimulation as a replacement for central nerve signalling, patients are freed from having to wear a leg brace. Production is currently outsourced to other companies in Denmark and Germany, but Neurodan aims to bring production to its home base in Aalborg. "It is a key product, that we want to have close to our development facilities," says Neurodan's MD Jesper Nielsen. The news was reported by regional daily newspaper Nordjyske.
Neurodan develops novel implantable devices which restore functionality to patients with central nerve damage through the application of Functional Electrical Stimulation and Neuro-Muscular Electrical Stimulation. These technologies replace central nerve signalling. The company originates from the internationally recognized Center for Sensory-Motor Interaction at Aalborg University, and was established in 1994 by Thomas Sinkjær and Morten Haugland.
Link > Neurodan   

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×